Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,034 | -10,669 | -3,917 | -20,213 | -14,610 |
| Depreciation Amortization | 2,029 | 1,305 | 654 | 1,890 | 1,427 |
| Accounts receivable | -4,043 | -4,681 | -6,039 | 1,065 | 713 |
| Accounts payable and accrued liabilities | -384 | 622 | 726 | -2,028 | -1,758 |
| Other Working Capital | 185 | -2,588 | -5,018 | -2,136 | -3,938 |
| Other Operating Activity | 12,852 | 5,362 | 5,944 | 1,997 | 1,352 |
| Operating Cash Flow | $-16,395 | $-10,649 | $-7,650 | $-19,425 | $-16,814 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -218 | -185 | -116 | -580 | -496 |
| Net Acquisitions | -5,849 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -544 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-6,611 | $-185 | $-116 | $-580 | $-496 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 24,005 | 15,126 | 6,714 | 23,844 | 17,402 |
| Debt Repayment | -21,456 | -13,107 | -3,583 | -21,300 | -15,371 |
| Common Stock Issued | 10,135 | 23 | N/A | 34,624 | 34,590 |
| Common Stock Repurchased | N/A | 42 | N/A | -14 | -14 |
| Other Financing Activity | 0 | 0 | 0 | -201 | 0 |
| Financing Cash Flow | $12,684 | $2,084 | $3,131 | $36,953 | $36,607 |
| Beginning Cash Position | 19,781 | 19,781 | 19,781 | 2,833 | 2,833 |
| End Cash Position | 9,459 | 11,031 | 15,146 | 19,781 | 22,130 |
| Net Cash Flow | $-10,322 | $-8,750 | $-4,635 | $16,948 | $19,297 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,395 | -10,649 | -7,650 | -19,425 | -16,814 |
| Capital Expenditure | -218 | -185 | -116 | -580 | -496 |
| Free Cash Flow | -16,613 | -10,834 | -7,766 | -20,005 | -17,310 |